Items where authors include "Rosenkranz, S."

Article

McLaughlin, V.V., Sitbon, O., Chin, K.M. et al. (11 more authors) (2024) Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities. European Journal of Heart Failure, 26 (11). pp. 2379-2391. ISSN 1388-9842

Lawrie, A. orcid.org/0000-0003-4192-9505, Chin, K., Fong, Y. et al. (14 more authors) (2024) Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): the CIPHER and CIPHER‐MRI studies. Pulmonary Circulation, 14 (2). e12386. ISSN 2045-8940

Torbicki, A. orcid.org/0000-0003-3475-8832, Channick, R., Galiè, N. et al. (9 more authors) (2024) Effect of macitentan in pulmonary arterial hypertension and the relationship between echocardiography and cMRI variables: REPAIR echocardiography sub-study results. Cardiology and Therapy, 13 (1). pp. 173-190. ISSN 2193-8261

Kiely, D.G. orcid.org/0000-0003-0184-6502, Channick, R., Flores, D. et al. (10 more authors) (2024) Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR. ERJ Open Research, 10 (1). 00547. ISSN 2312-0541

Hoeper, M.M., Dwivedi, K., Pausch, C. et al. (39 more authors) (2022) Phenotyping of idiopathic pulmonary arterial hypertension : a registry analysis. The Lancet Respiratory Medicine, 10 (10). pp. 937-948. ISSN 2213-2600

Vonk Noordegraaf, A., Channick, R., Cottreel, E. et al. (10 more authors) (2022) The REPAIR Study : effects of macitentan on RV structure and function in pulmonary arterial hypertension. JACC: Cardiovascular Imaging, 15 (2). pp. 240-253. ISSN 1936-878X

Sommer, N., Ghofrani, A., Pak, O. et al. (6 more authors) (2021) Current and future treatments of pulmonary arterial hypertension. British Journal of Pharmacology, 178 (1). pp. 6-30. ISSN 0007-1188